Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.
Ghia P, Pluta A, Wach M, Lysak D, Šimkovič M, Kriachok I, Illés Á, de la Serna J, Dolan S, Campbell P, Musuraca G, Jacob A, Avery EJ, Lee JH, Usenko G, Wang MH, Yu T, Jurczak W. Ghia P, et al. Among authors: lysak d. Hemasphere. 2022 Nov 14;6(12):e801. doi: 10.1097/HS9.0000000000000801. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36398134 Free PMC article.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Šimkovič M, Turcsányi P, Špaček M, Mihályová J, Ryznerová P, Maco M, Vodárek P, Écsiová D, Poul H, Móciková H, Zuchnická J, Panovská A, Lekaa M, Oršulová M, Prchlíková A, Stejskal L, Mašlejová S, Brychtová Y, Bezděková L, Papajík T, Lysák D, Trněný M, Smolej L, Doubek M. Šimkovič M, et al. Among authors: lysak d. Ann Hematol. 2023 Apr;102(4):811-817. doi: 10.1007/s00277-023-05147-z. Epub 2023 Feb 27. Ann Hematol. 2023. PMID: 36847805 Free PMC article.
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Špaček M, Smolej L, Šimkovič M, Nekvindová L, Křístková Z, Brychtová Y, Panovská A, Mašlejová S, Bezděková L, Écsiová D, Vodárek P, Zuchnická J, Mihályová J, Urbanová R, Turcsányi P, Lysák D, Novák J, Brejcha M, Líkařová T, Vodička P, Baranová J, Trněný M, Doubek M; Czech CLL Study Group. Špaček M, et al. Among authors: lysak d. Br J Haematol. 2023 Jul;202(1):40-47. doi: 10.1111/bjh.18736. Epub 2023 Mar 27. Br J Haematol. 2023. PMID: 36971061
13 C-depleted algae as food: Permitting background free in-vivo nuclear magnetic resonance of Daphnia magna at natural abundance.
Wolff WW, Pellizzari J, Soong R, Lysak DH, Steiner K, Ronda K, Costa P, Downey K, Moxley-Paquette V, Suszczynski C, Boehmer S, Prat JR, Simpson AJ. Wolff WW, et al. Among authors: lysak dh. Magn Reson Chem. 2024 Jan;62(1):11-18. doi: 10.1002/mrc.5409. Epub 2023 Nov 20. Magn Reson Chem. 2024. PMID: 37984890 No abstract available.
Low-field, not low quality: 1D simplification, selective detection, and heteronuclear 2D experiments for improving low-field NMR spectroscopy of environmental and biological samples.
Downey K, Bermel W, Soong R, Lysak DH, Ronda K, Steiner K, Costa PM, Wolff WW, Decker V, Busse F, Goerling B, Haber A, Simpson MJ, Simpson AJ. Downey K, et al. Among authors: lysak dh. Magn Reson Chem. 2024 May;62(5):345-360. doi: 10.1002/mrc.5401. Epub 2023 Oct 9. Magn Reson Chem. 2024. PMID: 37811556
Development of Low-Magnetic Susceptibility Microcoils via 5-Axis Machining for Analysis of Biological and Environmental Samples.
Moxley-Paquette V, Lane D, Steiner K, Downey K, Costa PM, Lysak DH, Ronda K, Soong R, Zverev D, De Castro P, Frei T, Stuessi J, Al Adwan-Stojilkovic D, Graf S, Gloor S, Schmidig D, Kuemmerle R, Kuehn T, Busse F, Utz M, Lacerda A, Nashman B, Albert L, Anders J, Simpson AJ. Moxley-Paquette V, et al. Among authors: lysak dh. Anal Chem. 2023 Sep 19;95(37):13932-13940. doi: 10.1021/acs.analchem.3c02437. Epub 2023 Sep 7. Anal Chem. 2023. PMID: 37676066
93 results